medication-betahistine-oral-daily-two-month

Outcomes

01
gastrointestinal-nausea-improvement-good-or-excellent-patient-rated-self-reported
1 evidence row
- parfenov-va_2017_cohort_effectiveness-of-betahistine-48-mg-day-in-vestibular-vertigo-virtuoso-study
02
gastrointestinal-nausea-improvement-good-or-excellent-physician-rated-self-reported
1 evidence row
- parfenov-va_2017_cohort_effectiveness-of-betahistine-48-mg-day-in-vestibular-vertigo-virtuoso-study
03
gastrointestinal-vomiting-improvement-good-or-excellent-patient-rated-self-reported
1 evidence row
- parfenov-va_2017_cohort_effectiveness-of-betahistine-48-mg-day-in-vestibular-vertigo-virtuoso-study
04
gastrointestinal-vomiting-improvement-good-or-excellent-physician-rated-self-reported
1 evidence row
- parfenov-va_2017_cohort_effectiveness-of-betahistine-48-mg-day-in-vestibular-vertigo-virtuoso-study
05
hearing-loss-improvement-good-or-excellent-measured
1 evidence row
- parfenov-va_2017_cohort_effectiveness-of-betahistine-48-mg-day-in-vestibular-vertigo-virtuoso-study
06
hearing-loss-improvement-good-or-excellent-self-reported
1 evidence row
- parfenov-va_2017_cohort_effectiveness-of-betahistine-48-mg-day-in-vestibular-vertigo-virtuoso-study
07
hearing-tinnitus-improvement-good-or-excellent-measured
1 evidence row
- parfenov-va_2017_cohort_effectiveness-of-betahistine-48-mg-day-in-vestibular-vertigo-virtuoso-study
08
hearing-tinnitus-improvement-good-or-excellent-self-reported
1 evidence row
- parfenov-va_2017_cohort_effectiveness-of-betahistine-48-mg-day-in-vestibular-vertigo-virtuoso-study
09
pain-headache-improvement-good-or-excellent-measured
1 evidence row
- parfenov-va_2017_cohort_effectiveness-of-betahistine-48-mg-day-in-vestibular-vertigo-virtuoso-study
10
pain-headache-improvement-good-or-excellent-self-reported
1 evidence row
- parfenov-va_2017_cohort_effectiveness-of-betahistine-48-mg-day-in-vestibular-vertigo-virtuoso-study
11
qol-overall-clinical-response-good-or-excellent-measured
1 evidence row
- parfenov-va_2017_cohort_effectiveness-of-betahistine-48-mg-day-in-vestibular-vertigo-virtuoso-study
12
qol-overall-clinical-response-good-or-excellent-self-reported
1 evidence row
- parfenov-va_2017_cohort_effectiveness-of-betahistine-48-mg-day-in-vestibular-vertigo-virtuoso-study
13
vestibular-faintness-improvement-good-or-excellent-measured
1 evidence row
- parfenov-va_2017_cohort_effectiveness-of-betahistine-48-mg-day-in-vestibular-vertigo-virtuoso-study
14
vestibular-faintness-improvement-good-or-excellent-self-reported
1 evidence row
- parfenov-va_2017_cohort_effectiveness-of-betahistine-48-mg-day-in-vestibular-vertigo-virtuoso-study
15
vestibular-vertigo-monthly-attack-frequency-change-from-baseline-to-end-of-treatment-count-self-reported
1 evidence row
- parfenov-va_2017_cohort_effectiveness-of-betahistine-48-mg-day-in-vestibular-vertigo-virtuoso-study
16
vestibular-vertigo-monthly-attack-frequency-change-from-end-of-treatment-to-2-month-follow-up-count-self-reported
1 evidence row
- parfenov-va_2017_cohort_effectiveness-of-betahistine-48-mg-day-in-vestibular-vertigo-virtuoso-study
17
vestibular-vertigo-severity-level-change-from-baseline-to-end-of-treatment-self-reported
1 evidence row
- parfenov-va_2017_cohort_effectiveness-of-betahistine-48-mg-day-in-vestibular-vertigo-virtuoso-study

medication-betahistine-oral-daily-two-month

Outcomes

gastrointestinal-nausea-improvement-good-or-excellent-patient-rated-self-reported

gastrointestinal-nausea-improvement-good-or-excellent-physician-rated-self-reported

gastrointestinal-vomiting-improvement-good-or-excellent-patient-rated-self-reported

gastrointestinal-vomiting-improvement-good-or-excellent-physician-rated-self-reported

hearing-loss-improvement-good-or-excellent-measured

hearing-loss-improvement-good-or-excellent-self-reported

hearing-tinnitus-improvement-good-or-excellent-measured

hearing-tinnitus-improvement-good-or-excellent-self-reported

pain-headache-improvement-good-or-excellent-measured

pain-headache-improvement-good-or-excellent-self-reported

qol-overall-clinical-response-good-or-excellent-measured

qol-overall-clinical-response-good-or-excellent-self-reported

vestibular-faintness-improvement-good-or-excellent-measured

vestibular-faintness-improvement-good-or-excellent-self-reported

vestibular-vertigo-monthly-attack-frequency-change-from-baseline-to-end-of-treatment-count-self-reported

vestibular-vertigo-monthly-attack-frequency-change-from-end-of-treatment-to-2-month-follow-up-count-self-reported

vestibular-vertigo-severity-level-change-from-baseline-to-end-of-treatment-self-reported